|
1
|
Kreis T and Vale R: Guidebook to the
Extracellular MatrixAnchor and Adhesion Proteins. 2nd. Oxford
University Press; 1999
|
|
2
|
Okegawa T, Li Y, Pong RC and Hsieh JT:
Cell adhesion proteins as tumor suppressors. J Urol. 167:1836–1843.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Moh MC and Shen S: The roles of cell
adhesion molecules in tumor suppression and cell migration: A new
paradox. Cell Adh Migr. 3:334–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pećina-Slaus N: Tumor suppressor gene
E-cadherin and its role in normal and malignant cells. Cancer Cell
Int. 3:172003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren B, Yu YP, Tseng GC, Wu C, Chen K, Rao
UN, Nelson J, Michalopoulos GK and Luo JH: Analysis of integrin
alpha7 mutations in prostate cancer, liver cancer, glioblastoma
multiforme, and leiomyosarcoma. J Natl Cancer Inst. 99:868–880.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heller G, Geradts J, Ziegler B, Newsham I,
Filipits M, Markis-Ritzinger EM, Kandioler D, Berger W, Stiglbauer
W, Depisch D, et al: Downregulation of TSLC1 and DAL-1 expression
occurs frequently in breast cancer. Breast Cancer Res Treat.
103:283–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ito T, Shimada Y, Hashimoto Y, Kaganoi J,
Kan T, Watanabe G, Murakami Y and Imamura M: Involvement of TSLC1
in progression of esophageal squamous cell carcinoma. Cancer Res.
63:6320–6326. 2003.PubMed/NCBI
|
|
8
|
Wiedemann M and Trueb B: Characterization
of a novel protein (FGFRL1) from human cartilage related to FGF
receptors. Genomics. 69:275–279. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Trueb B: Biology of FGFRL1, the fifth
fibroblast growth factor receptor. Cell Mol Life Sci. 68:951–964.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Trueb B, Zhuang L, Taeschler S and
Wiedemann M: Characterization of FGFRL1, a novel fibroblast growth
factor (FGF) receptor preferentially expressed in skeletal tissues.
J Biol Chem. 278:33857–33865. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ornitz DM and Itoh N: The fibroblast
growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol.
4:215–266. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gerber SD, Steinberg F, Beyeler M,
Villiger PM and Trueb B: The murine Fgfrl1 receptor is essential
for the development of the metanephric kidney. Dev Biol.
335:106–119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Baertschi S, Zhuang L and Trueb B: Mice
with a targeted disruption of the Fgfrl1 gene die at birth due to
alterations in the diaphragm. FEBS J. 274:6241–6253. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amann R, Wyder S, Slavotinek AM and Trueb
B: The FgfrL1 receptor is required for development of slow muscle
fibers. Dev Biol. 394:228–241. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rieckmann T, Kotevic I and Trueb B: The
cell surface receptor FGFRL1 forms constitutive dimers that promote
cell adhesion. Exp Cell Res. 314:1071–1081. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Steinberg F, Gerber SD, Rieckmann T and
Trueb B: Rapid fusion and syncytium formation of heterologous cells
upon expression of the FGFRL1 receptor. J Biol Chem.
285:37704–37715. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang X, Steinberg F, Zhuang L, Bessey R
and Trueb B: Receptor FGFRL1 does not promote cell proliferation
but induces cell adhesion. Int J Mol Med. 38:30–38. 2016.PubMed/NCBI
|
|
18
|
Zhuang L, Gerber SD, Kuchen S, Villiger PM
and Trueb B: Deletion of exon 8 from the EXT1 gene causes multiple
osteochondromas (MO) in a family with three affected members.
Springerplus. 5:712016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rieckmann T, Zhuang L, Flück CE and Trueb
B: Characterization of the first FGFRL1 mutation identified in a
craniosynostosis patient. Biochim Biophys Acta. 1792:112–121. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Henning A, Schneider M, Bur M, Blank F,
Gehr P and Lehr CM: Embryonic chicken trachea as a new in vitro
model for the investigation of mucociliary particle clearance in
the airways. AAPS PharmSciTech. 9:521–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhuang L, Falquet L and Trueb B:
Genome-wide comparison of FGFRL1 with structurally related surface
receptors. Exp Ther Med. 1:161–168. 2010.PubMed/NCBI
|
|
22
|
Mandai K, Rikitake Y, Mori M and Takai Y:
Nectins and nectin-like molecules in development and disease. Curr
Top Dev Biol. 112:197–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Samanta D and Almo SC: Nectin family of
cell-adhesion molecules: Structural and molecular aspects of
function and specificity. Cell Mol Life Sci. 72:645–658. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen C, Gu M, Song C, Miao L, Hu L, Liang
D and Zheng C: The tumorigenicity diversification in human
embryonic kidney 293 cell line cultured in vitro. Biologicals.
36:263–268. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka T and Rabbitts TH: Interfering with
RAS-effector protein interactions prevent RAS-dependent tumour
initiation and causes stop-start control of cancer growth.
Oncogene. 29:6064–6070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schild C and Trueb: Aberrant expression of
FGFRL1, a novel FGF receptor, in ovarian tumors. Int J Mol Med.
16:1169–1173. 2005.PubMed/NCBI
|
|
27
|
Barrett CL, DeBoever C, Jepsen K, Saenz
CC, Carson DA and Frazer KA: Systematic transcriptome analysis
reveals tumor-specific isoforms for ovarian cancer diagnosis and
therapy. Proc Natl Acad Sci USA. 112:E3050–E3057. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsuchiya S, Fujiwara T, Sato F, Shimada Y,
Tanaka E, Sakai Y, Shimizu K and Tsujimoto G: MicroRNA-210
regulates cancer cell proliferation through targeting fibroblast
growth factor receptor-like 1 (FGFRL1). J Biol Chem. 286:420–428.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shimada Y, Okumura T, Nagata T, Hashimoto
I, Sawada S, Yoshida T, Fukuoka J, Shimizu K and Tsukada K:
Expression analysis of fibroblast growth factor receptor-like 1
(FGFRL1) in esophageal squamous cell carcinoma. Esophagus.
11:48–53. 2014. View Article : Google Scholar
|
|
30
|
di Martino E, Taylor CF, Roulson JA and
Knowles MA: An integrated genomic, transcriptional and protein
investigation of FGFRL1 as a putative 4p16.3 deletion target in
bladder cancer. Genes Chromosomes Cancer. 52:860–871. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Donnard E, Asprino PF, Correa BR, Bettoni
F, Koyama FC, Navarro FC, Perez RO, Mariadason J, Sieber OM,
Strausberg RL, et al: Mutational analysis of genes coding for cell
surface proteins in colorectal cancer cell lines reveal novel
altered pathways, druggable mutations and mutated epitopes for
targeted therapy. Oncotarget. 5:9199–9213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Murakami S, Sakurai-Yageta M, Maruyama T
and Murakami Y: Trans-homophilic interaction of CADM1 activates
PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg.
PLoS One. 9:e1100622014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang X, Ding L, Bennewith KL, Tong RT,
Welford SM, Ang KK, Story M, Le QT and Giaccia AJ:
Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell. 35:856–867. 2009.
View Article : Google Scholar : PubMed/NCBI
|
